Physician profile
Britney E Leffall
NPI 1467910455
$2,493.17
in general payments reported to CMS, 2019-2025
10 companies · $594 in 2025
The $594 reported for 2025 was more than what 80% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $351 · 2022: $20.04 · 2024: $1,528 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,128 · Food and Beverage: $914 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,128.20 |
| Food and Beverage | $913.64 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,527.59 | 2024 | Hemosphere |
| Abiomed | $284.12 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $167.51 | 2025 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $134.36 | 2025 | Opsumit, Uptravi |
| Livanova USA, INC. | $111.99 | 2021 | |
| La Jolla Pharmaceutical Company | $107.12 | 2021 | |
| Astellas Pharma US INC | $79.99 | 2025 | |
| Abbvie INC. | $36.62 | 2025 | |
| Baxter Healthcare | $23.83 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Sanofi-Aventis U.S. LLC | $20.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britney Leffall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.